Trump's former FDA commissioner: ‘It will cost lives in this country' if RFK Jr. follows through on intentions
Dr. Scott Gottlieb, Trump’s former FDA commissioner, said he has concerns about the president-elect’s pick for health secretary.
Scott Got­tlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this coun­try’
Former FDA commissioner Scott Gottlieb came out against president-elect Trump’s choice of Robert F. Kennedy Jr. to lead the Department of Health and Human Services, saying his policies would lead to a resurgence of preventable diseases and cost lives.
RFK Jr. could 'cost lives in this country' if he pursues changes to US vaccine policy, Gottlieb says
Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services immediately sent waves of speculation swirling throughout the biopharma industry. | The former FDA Commissioner pointed to the threat of measles if vaccination rates were to decline by 5%.
Ex-FDA Commissioner Says RFK Jr. 'Will Cost Lives' As Head Of Health Department
Scott Gottlieb, who served early on in Trump's first term, is now warning senators about the impact Kennedy could have on public health.
Former FDA Commissioner Scott Gottlieb: RFK Jr. Will Cost Lives In This Country, Vaccination Rates Will Go Down
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk Box' to discuss the incoming Trump administration's picks for health cabinet positions, including HHS Secretary Robert F.
Gottlieb: RFK Jr. ‘will cost lives’ if he follows through on health plans
Scott Gottlieb, who served as commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first term, expressed concerns with the pick of Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS) due to his anti-vaccine advocacy.
Former Trump FDA chief is seeking to undermine RFK Jr.’s Senate confirmation
Former FDA Commissioner Scott Gottlieb, who served in the first Trump administration, is raising concerns with Republicans about RFK Jr's. nomination to lead HHS.
Fmr. FDA Commissioner on how Trump could impact GLP-1 industry
Dr. Scott Gottlieb joins 'Fast Money' to talk how a Trump administration could impact the GLP-1 drug industry.
STAT10h
Despite probe, China reimbursing AstraZeneca drug
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
The New Civil Rights Movement2d
‘Will Cost Lives’: Ex-FDA Chief Warns Trump Picks Could Lead to ‘Grim’ Disease Resurgence
Dr. Scott Gottlieb, the Commissioner of the Food and Drug Administration during Donald Trump’s first administration, has ...
Dr. Scott Gottlieb on RFK: He will cost lives in this country if he follows through on intentions
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk Box' to discuss the incoming administration's ...
STAT11h
Pharmalittle: We’re reading about a former Trump FDA chief criticizing RFK Jr., a radiopharmaceuticals talent shortage, and more
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of ...